PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatocellular carcinoma |
| Symptom | |liver disease |
| Sentences | 81 |
| PubMedID- 26201636 | Purpose: metabolic syndrome (ms) is a group of recognized risk factors for the development of hepatocellular carcinoma (hcc) in patients with chronic liver disease. |
| PubMedID- 25103596 | Aims: to evaluate the value of spleen and liver apparent diffusion coefficients (adc) in chronic liver disease patients, with and without hepatocellular carcinoma (hcc), and to investigate the use of diffusion-weighted imaging (dwi) in the diagnosis and follow-up of hepatic fibrosis. |
| PubMedID- 22167508 | Small (hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 t mri and multiphasic 64-multirow detector ct. |
| PubMedID- 20956466 | This prospective study aimed to compare the diagnostic performance of (18)f-fluorocholine and (18)f-fdg for detecting and staging hepatocellular carcinoma (hcc) in patients with chronic liver disease and suspected liver nodules. |
| PubMedID- 20227190 | For hepatocellular carcinoma, most often without underlying liver disease in children of the western world, results of resection with partial hepatectomy remain dismal, due to a high rate of recurrence. |
| PubMedID- 23144154 | Interleukin-6 and oncostatin m are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker gp73. |
| PubMedID- 23140577 | Hepatitis c virus (hcv) is a hepacivirus that causes chronic liver disease, leading to hepatocellular carcinoma, cirrhosis, and chronic hepatitis in about 3% of the world population. |
| PubMedID- 24459650 | Hepatic abscess mimicking hepatocellular carcinoma in a patient with alcoholic liver disease. |
| PubMedID- 26389885 | The role of this polymorphism in liver pathology is further suggested by its association with increased risk of non-alcoholic steatohepatitis , liver cirrhosis , and hepatocellular carcinoma in patients with underlying liver disease . |
| PubMedID- 24588677 | Purpose: to assess diagnostic performance and imaging features of gadoxetic acid-enhanced magnetic resonance (mr) imaging in small (hepatocellular carcinoma (hcc) detection in patients with chronic liver disease. |
| PubMedID- 22869157 | This study was conducted to determine whether pnpla3 rs738409 snps affect development and prognosis of hepatocellular carcinoma (hcc) in patients with various liver diseases. |
| PubMedID- 26473344 | Nonalcoholic fatty liver disease (nafld) can lead to cirrhosis, hepatocellular carcinoma, and ultimately death. |
| PubMedID- 21545731 | Hcv infection is frequently associated with chronic liver diseases and development of hepatocellular carcinoma. |
| PubMedID- 26274335 | Association of nonalcoholic fatty liver disease (nafld) with hepatocellular carcinoma (hcc) in the united states from 2004 to 2009. |
| PubMedID- 24801168 | As effective antifibrotic therapies are developed, these approaches could attenuate the rising surge of hepatocellular carcinoma associated with chronic liver disease. |
| PubMedID- 20148264 | Purpose: the optimum strategy, hepatic resection (hr) or liver transplantation (lt), for treatment of early hepatocellular carcinoma (hcc) associated with liver diseases of child-pugh a is far from established. |
| PubMedID- 23146507 | Background: liver transplantation (olt) represents the treatment of choice for small hepatocellular carcinomas (hcc) in patients with end-stage liver disease. |
| PubMedID- 21472122 | Obi might contribute to the progression of liver fibrosis and hepatocellular carcinoma development in patients with chronic liver disease. |
| PubMedID- 24658135 | Exclusion criteria for hcv and hbv patients were: 1) previous treatment with antiviral therapy, immunosuppressive drugs, and/or regular use of drugs influencing lipid metabolism and/or oxidative stress; 2) advanced cirrhosis; 3) hepatocellular carcinoma; 4) other causes of liver disease or mixed etiologies; 5) human immunodeficiency virus infection; 6) active intravenous drug addiction, 7) alcohol consumption. |
| PubMedID- 23227248 | Exclusion criteria were: (1) advanced cirrhosis; (2) hepatocellular carcinoma; (3) other causes of liver disease or mixed aetiologies; (4) human immunodeficiency virus infection; (5) previous treatment with antiviral therapy, immunosuppressive drugs and/or regular use of steatosis-inducing drugs, evaluated by interview; (6) active intravenous drug addiction. |
| PubMedID- 23905813 | The extended immune clearance phase is associated with liver disease progression, including development of cirrhosis and hepatocellular carcinoma (hcc). |
| PubMedID- 25744657 | Purpose: the incidence of hepatocellular carcinoma (hcc) in patients with nonalcoholic fatty liver disease (nafld) is increasing. |
| PubMedID- 22814828 | Objective: to examine if liver stiffness measured by magnetic resonance elastography (mre) is a risk factor for hepatocellular carcinoma (hcc) in patients with chronic liver disease. |
| PubMedID- 21418304 | Ubiquitin-proteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 21688080 | Open liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: a case-matched study. |
| PubMedID- 26456168 | Background: in japan, the prevalence of hepatocellular carcinoma (hcc) associated with nonviral liver disease, especially with nonalcoholic fatty liver disease (nafld-hcc) and alcoholic liver disease (ald-hcc), has been increasing. |
| PubMedID- 22174525 | A 70-year-old man, with h/o chronic liver disease and suspected of hepatocellular carcinoma serum alpha-fetoprotein (afp) 5024 ng/ml was subjected to fluorine-18 fluorodeoxyglucose positron emission tomography (f-18 fdg pet)/computed tomography (ct) imaging. |
| PubMedID- 24838304 | Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase mr imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 21667042 | Important exclusion criteria were decompensated liver disease or evidence of hepatocellular carcinoma (based on liver biopsy within the previous 2 years), coinfection with hepatitis b virus (hbv) or human immunodeficiency virus (hiv) and current or near future pregnancy. |
| PubMedID- 23903617 | Conclusions: chronic hepatitis c, followed by ethanol abuse and chronic hepatitis b were the leading causes of underlying chronic liver disease associated with hepatocellular carcinoma. |
| PubMedID- 24313165 | Epigenetic mechanisms play an extensive role in the development of liver cancer (i.e., hepatocellular carcinoma hcc) associated with alcoholic liver disease (ald) as well as in liver disease associated with other conditions. |
Page: 1 2